Mount Yale Investment Advisors LLC Trims Stake in Colgate-Palmolive (NYSE:CL)

Mount Yale Investment Advisors LLC lowered its holdings in Colgate-Palmolive (NYSE:CL) by 28.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,126 shares of the company’s stock after selling 1,213 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $324,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Main Street Research LLC raised its position in Colgate-Palmolive by 1.5% in the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after purchasing an additional 100 shares during the period. Advisor OS LLC grew its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock valued at $228,000 after buying an additional 101 shares in the last quarter. BLB&B Advisors LLC grew its stake in shares of Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after buying an additional 104 shares in the last quarter. ZWJ Investment Counsel Inc. grew its stake in shares of Colgate-Palmolive by 3.1% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after buying an additional 109 shares in the last quarter. Finally, Hexagon Capital Partners LLC grew its stake in shares of Colgate-Palmolive by 9.5% in the second quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock valued at $124,000 after buying an additional 110 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 4.1 %

Colgate-Palmolive stock opened at $95.61 on Monday. Colgate-Palmolive has a fifty-two week low of $71.46 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The company has a market capitalization of $78.44 billion, a P/E ratio of 30.26, a PEG ratio of 3.54 and a beta of 0.40. The stock has a 50-day simple moving average of $103.15 and a 200-day simple moving average of $98.06.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.03. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.03 billion during the quarter, compared to the consensus estimate of $5.01 billion. Equities research analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.09%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 63.29%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CL shares. Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. UBS Group boosted their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Finally, JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $106.00.

Insider Activity

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 43,490 shares of company stock valued at $4,486,063. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.